AZN vs IVZ · P/E 28, $288.38B cap vs rev $3.57B
AstraZeneca PLC (AZN) versus Invesco Plc (IVZ) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Invesco Plc (IVZ) is a asset management company listed on NYSE.
AZN does not have a complete income-statement cache yet.
Latest reported IVZ revenue for 2026-06-30 was $3.57B. Net income was $558.0M. IVZ currently screens at market cap $12.76B.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. IVZ currently screens at market cap $12.76B.
Not investment advice. Open the AZN and IVZ stock pages for the full models.
Not investment advice.